article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

It attributed Indias cost advantage to high-production capacity plants, process improvements, economies of scale, and backward integration in manufacturing. On the pricing of generics, IPA stated, While generics are priced lower than the corresponding brands, it is unfair and unacceptable to link quality with cost.

article thumbnail

The next industrial revolution in India will be driven by biotechnology

Express Pharma

He noted that the number of biotech startups has risen from just 50 in 2014 to over 5,000 now, reflecting India’s increasing focus on bioeconomy. He praised the reforms undertaken by the Government in the last decade, which have helped the industry thrive, particularly through structural and process improvements.

Vaccines 105